Analyzing Auna (NYSE:AUNA) and biote (NASDAQ:BTMD)

biote (NASDAQ:BTMD – Get Free Report) and Auna (NYSE:AUNA – Get Free Report) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, valuation, dividends, profitability, risk and analyst recommendations.

Earnings & Valuation

This table compares biote and Auna”s gross revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
biote $178.91 million 0.20 $27.05 million ($0.10) -9.73
Auna $4.67 billion 0.07 $27.39 million $0.07 66.09

Auna has higher revenue and earnings than biote. biote is trading at a lower price-to-earnings ratio than Auna, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

biote has a beta of 1.73, indicating that its share price is 73% more volatile than the S&P 500. Comparatively, Auna has a beta of 0.67, indicating that its share price is 33% less volatile than the S&P 500.

Analyst Ratings

This is a breakdown of current ratings and price targets for biote and Auna, as reported by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
biote 1 1 1 1 2.50
Auna 1 2 1 1 2.40

biote currently has a consensus target price of $2.50, suggesting a potential upside of 156.94%. Auna has a consensus target price of $6.97, suggesting a potential upside of 50.60%. Given biote’s stronger consensus rating and higher possible upside, equities analysts clearly believe biote is more favorable than Auna.

Profitability

This table compares biote and Auna’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
biote -1.08% -8.61% 4.61%
Auna 0.44% 12.88% 3.24%

Institutional & Insider Ownership

21.7% of biote shares are owned by institutional investors. 32.4% of biote shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

biote beats Auna on 7 of the 13 factors compared between the two stocks.

About biote

(Get Free Report)

Biote is a medical technology and services company focused on hormone optimization. It supports healthcare providers who offer bioidentical hormone replacement therapy (BHRT), including pellet-based treatment programs for eligible patients. The company’s services include provider training and education, patient and practice support, and hormone testing and treatment protocols. Biote also offers nutritional supplements and related wellness products through participating providers. Biote was founded in 2012 and serves a network of healthcare providers in the United States.

About Auna

(Get Free Report)

Auna S.A. is a Latin American healthcare company that provides medical care through a network of hospitals, clinics and specialized treatment centers. Its services include general and specialty care, diagnostic services and cancer treatment. The company also offers health plans and other healthcare financing services, integrating coverage with care delivery. Auna serves patients in Peru, Colombia and Mexico.

Receive News & Ratings for biote Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for biote and related companies with MarketBeat.com's FREE daily email newsletter.